Jonathan Zalevsky Nektar Therapeutics (NKTR) insider trading activity

NKTR Quotes by TradingView

Jonathan Zalevsky is Chief R&D Officer of NEKTAR THERAPEUTICS. Currently has a direct ownership of 326,904 shares of NKTR, which is worth approximately $304,020. The most recent transaction as insider was on Nov 16, 2020, when has been sold 29,618 shares (Common Stock) at a price of $16.93 per share, resulting in proceeds of $501,433. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 327K
30.34% 3M change
19.29% 12M change
Total Value Held $304,020

Jonathan Zalevsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2020
SELL
Open market or private sale
$501,433 $16.93 p/Share
29,618 Reduced 10.0%
266,697 Common Stock
JZ

Jonathan Zalevsky

Chief R&D Officer
San Francisco, CA

Track Institutional and Insider Activities on NKTR

Follow NEKTAR THERAPEUTICS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

News

Receive news related to NEKTAR THERAPEUTICS

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NKTR